EraNova Metals Reports Samples of up to 257 g/t Gold and 3,660 g/t Silver at Lakeview and Defines New Drill Target on the Ruby Creek Property Life Science Investing
Palvella Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares Life Science Investing
BioAtla Announces Formal Process to Evaluate Strategic Options to Monetize Assets Life Science Investing
Dyne Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights Life Science Investing
Sionna Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results Life Science Investing
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform Life Science Investing
NRx Pharmaceuticals Appoints Prof. Joshua Brown MD, PhD, as Chief Medical Innovation Officer Life Science Investing
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing Life Science Investing
Zymeworks and Royalty Pharma Enter into $250 Million Royalty-Backed Note Financing Life Science Investing
Atrium Therapeutics Launches with Approximately $270 Million to Advance Novel RNA Medicines for Rare Genetic Cardiomyopathies Life Science Investing
RenovoRx Advancing RenovoCath® Adoption at U.S. Cancer Centers, Strengthening Clinical and Commercial Momentum Life Science Investing